Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-25

Clinical Trial Update: Identifying Therapeutic Hemodialysis Targets Through Cerebrovascular Reactivity; RESPIRACT 2

View source ↗

Summary

This entry reports on RESPIRACT 2, a clinical trial exploring cerebrovascular reactivity to identify therapeutic hemodialysis targets in patients with chronic k…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Chronic Kidney Failure | Status: ACTIVE_NOT_RECRUITING